19:50 IST
BSE
Management Change
Kabra Drugs Management Change
Director Ms. Anand Anitha has resigned from the Board of Aanjaay Industries Limited, effective August 12, 2026, citing personal reasons.
Kabra Drugs Ltd
- Share price
- ₹18.65
- Market cap
- ₹44.22 Cr
- Revenue (annual)
- ₹92.74 Cr
- Net profit (annual)
- ₹4.96 Cr
- P/E (TTM)
- 5.8×Sector 47.4×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 4Board Meeting Date 4Annual General Meeting 4Financial Results 3Board Meeting Outcome 3Management Change 2Capacity Expansion 2Results Update 1Legal & Regulatory 1Capital Structure Change 1Annual Report 1
Time
2 announcements with these filters
18:49 IST
BSE
Management Change
Kabra Drugs Management Change
Kabra Drugs Limited appointed Ms. Monam Kapoor as an Additional Non-Executive Independent Director for a five-year term starting April 21, 2026. Ms. Kapoor is a BCA graduate with professional experience at Techtone (HK) Energy Company. The appointment is subject to shareholder approval and follows recommendations from the Nomination and Remuneration Committee.
- Execution
- 5 years